Alexander Nowak
Stock Analyst at Craig-Hallum
(2.55)
# 2,316
Out of 4,920 analysts
45
Total ratings
41.67%
Success rate
4.8%
Average return
Main Sectors:
Stocks Rated by Alexander Nowak
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVRX CVRx, Inc. | Maintains: Buy | $20 → $22 | $6.81 | +223.29% | 5 | Jan 17, 2025 | |
| NTRA Natera | Maintains: Buy | $121 → $157 | $140.12 | +12.05% | 4 | Nov 13, 2024 | |
| BVS Bioventus | Maintains: Buy | $12 → $17 | $6.14 | +176.87% | 6 | Sep 27, 2024 | |
| QDEL QuidelOrtho | Upgrades: Buy | $40 → $57 | $23.68 | +140.71% | 6 | Sep 5, 2024 | |
| CELC Celcuity | Assumes: Buy | $25 → $27 | $42.84 | -36.97% | 2 | May 16, 2024 | |
| CDNA CareDx | Upgrades: Buy | $12 → $15 | $12.85 | +16.73% | 3 | May 1, 2024 | |
| DMAC DiaMedica Therapeutics | Assumes: Buy | $8 | $4.49 | +78.17% | 4 | Apr 24, 2024 | |
| LUNG Pulmonx | Initiates: Buy | $18 | $1.64 | +997.56% | 1 | Sep 5, 2023 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $74 → $50 | $15.15 | +230.03% | 2 | Jun 13, 2023 | |
| DRIO DarioHealth | Maintains: Buy | $14 → $8 | $0.53 | +1,409.15% | 1 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $47.36 | - | 1 | Oct 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.81 | - | 2 | Mar 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $2.24 | +391.07% | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $88 → $110 | $54.64 | +101.32% | 3 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | n/a | $0.51 | - | 2 | Jan 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $300 | $4.93 | +5,985.19% | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $6.07 | +361.29% | 1 | Aug 31, 2020 |
CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20 → $22
Current: $6.81
Upside: +223.29%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121 → $157
Current: $140.12
Upside: +12.05%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $6.14
Upside: +176.87%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40 → $57
Current: $23.68
Upside: +140.71%
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25 → $27
Current: $42.84
Upside: -36.97%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12 → $15
Current: $12.85
Upside: +16.73%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $4.49
Upside: +78.17%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $1.64
Upside: +997.56%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74 → $50
Current: $15.15
Upside: +230.03%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $14 → $8
Current: $0.53
Upside: +1,409.15%
Oct 19, 2022
Downgrades: Hold
Price Target: n/a
Current: $47.36
Upside: -
Mar 28, 2022
Downgrades: Hold
Price Target: n/a
Current: $0.81
Upside: -
Jan 5, 2022
Initiates: Buy
Price Target: $11
Current: $2.24
Upside: +391.07%
Feb 3, 2021
Maintains: Buy
Price Target: $88 → $110
Current: $54.64
Upside: +101.32%
Jan 20, 2021
Downgrades: Sell
Price Target: n/a
Current: $0.51
Upside: -
Jan 11, 2021
Initiates: Buy
Price Target: $300
Current: $4.93
Upside: +5,985.19%
Aug 31, 2020
Initiates: Buy
Price Target: $28
Current: $6.07
Upside: +361.29%